聚乙二醇干扰素
医学
药疹
慢性肝炎
干扰素
皮肤病科
药品
药理学
内科学
免疫学
利巴韦林
病毒
作者
Şener Barut,Jale Yüksek,Engin Sezer,Özgür Günal,Dogan Koseoglu
标识
DOI:10.1111/j.1346-8138.2010.01088.x
摘要
Abstract Pegylated or non‐pegylated α‐interferon are frequently used medications for the treatment of both chronic hepatitis B and chronic hepatitis C. Skin disorders, which are mainly comprised of eczematous dermatitis, are frequently seen during treatment with this drug. However, drug eruption or morbilliform eruptions due to interferons have been rarely reported so far. We herein describe a patient who developed morbilliform drug eruption under treatment with pegylated interferon. She was able to continue treatment after switching from pegylated interferon to conventional interferon.
科研通智能强力驱动
Strongly Powered by AbleSci AI